Until improvements under development can be broadly implemented, routine confirmatory testing in active surveillance for ...

MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...

MRI does not reliably exclude clinically significant prostate cancer in about one quarter of patients receiving active surveillance, confirming that MRI is not a substitute for biopsy.

The goal of this investigation was to retrospectively compare the recently proposed Prostate Imaging Reporting and Data System (PI-RADS) scale with the older Likert scale, using multiparametric MRI in ...

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

The Prostate Imaging Reporting and Data System (PI-RADS) was mainly developed for the purposes of prostate cancer (PCa) detection. However, its widespread use suggests that it may play a role in a ...

Combining PSA density with prostate MRI findings improves the predictive performance of PI-RADS in men without a prior prostate cancer diagnosis. Combining PSA density (PSAD) with prostate magnetic ...

Baseline MRI PI-RADS score suggests prognosis and may improve upfront risk stratification and eligibility for prostate cancer active surveillance. Higher baseline MRI PI-RADS score is associated with ...